Pazopanib Hydrochloride
| CAS No. | 635702-64-6 |
|---|---|
| MDL No. | MFCD12546138 |
| MF | C21H24ClN7O2S |
| MW | 474.00 |
| InChI Key | MQHIQUBXFFAOMK-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Pazopanib hydrochloride is a hydrochloride salt formed from equimolar amounts of pazopanib and hydrochloric acid. It is used in the treatment of kidney cancer and functions as an antineoplastic agent, vascular endothelial growth factor receptor antagonist, tyrosine kinase inhibitor, and angiogenesis modulating agent. It contains pazopanib(1+).
| CAS No. | 635702-64-6 |
|---|---|
| Product Name | Pazopanib Hydrochloride |
Biological Targets
FGFR1·FGFR3·CSF1R·PDGFRB·PDGFRA·
Associated Conditions
peritoneum cancer·collecting duct carcinoma·follicular thyroid carcinoma·adrenal gland pheochromocytoma·urinary bladder cancer·
* The information provided here is compiled from public sources and is for reference only.
